- This blog is a discussion about our system of public and private health care.
-

Blogroll
About Me
Alison Bass is a Pulitzer Prize nominee and author of Side Effects: A Prosecutor, a Whistleblower and a Bestselling Antidepressant on Trial, which won the NASW Science in Society Award. She was a longtime medical and science writer for The Boston Globe and has also written for The Miami Herald, Psychology Today and MIT's Technology Review, among other publications. A series she wrote for The Boston Globe on psychiatry was nominated for a Pulitzer Prize and she has received many other journalism awards. In 2007, she won a prestigious Alicia Patterson Fellowship to write Side Effects. Bass teaches journalism at Mount Holyoke College and Brandeis University.Blog Archive
- June 2013 (1)
- February 2013 (1)
- November 2012 (1)
- October 2012 (1)
- September 2012 (4)
- August 2012 (1)
- July 2012 (2)
- June 2012 (3)
- May 2012 (3)
- April 2012 (2)
- February 2012 (2)
- January 2012 (3)
- December 2011 (3)
- November 2011 (3)
- October 2011 (2)
- September 2011 (4)
- August 2011 (3)
- July 2011 (3)
- June 2011 (4)
- May 2011 (4)
- April 2011 (3)
- March 2011 (3)
- February 2011 (3)
- January 2011 (4)
- December 2010 (3)
- November 2010 (2)
- September 2010 (2)
- July 2010 (1)
- May 2010 (1)
- April 2010 (1)
- March 2010 (3)
- February 2010 (3)
- January 2010 (4)
- December 2009 (4)
- November 2009 (5)
- October 2009 (4)
- September 2009 (6)
- August 2009 (7)
- July 2009 (4)
- June 2009 (5)
- May 2009 (4)
- April 2009 (7)
- March 2009 (4)
- February 2009 (3)
- January 2009 (4)
- December 2008 (4)
- November 2008 (3)
- October 2008 (4)
- September 2008 (5)
- August 2008 (2)
- July 2008 (6)
- June 2008 (5)
- May 2008 (1)
- April 2008 (1)
Monthly Archives: March 2010
Shining the light on drug company shell games
Share First the good news: The Physician Payment Sunshine Act is now law, signed by President Obama as part of the health care bill overhaul. Starting in 2012, drug and medical device companies must report all consulting, speaking and other … Continue reading
Posted in Uncategorized
1 Comment
Why tort reform isn’t on the table: hard lessons about special interest money in Washington
Share Every semester, I do an in-class competition to show my students the power of the Web in digging up data for stories. I separate them into groups and ask them to find the answers to specific questions about current … Continue reading
Posted in Uncategorized
2 Comments
Financial conflicts and other problems with the proposed DSM-V
Share I have hesitated to weigh in on the debate raging over the proposed changes to the DSM-V (psychiatry’s diagnostic bible), in large part because others more literate in psychiatric minutiae have already done so. To wit: Dr. Allen Frances … Continue reading
Posted in Uncategorized
Leave a comment